4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-035688
Director acquired 3,860 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NARACHI MICHAEL Director | 2023-06-07 | Grant or award | +3,860 | 21,605 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| NARACHI MICHAEL Director | 2023-06-07 | Grant or award · Common Stock | +7,110 | 7,110 | D: show line 2 in the form |
Loading xslF345X04/doc4.xml…